Featured News

The Washington Post Editorial Board cited a joint-letter co-authored and endorsed by GHTC in an opinion piece calling for the Administration to provide funding to sustain the US Centers for Disease Control and Prevention activities to support he Global Health Security Agenda.

Learn More
University of Maryland Institute of Human Virology
GHTC welcomes Robert Redfield as CDC director

GHTC sent a letter welcoming Dr. Robert Redfield as the new Centers for Disease Control and Prevention (CDC) director and urging him to prioritize global health R&D at CDC.

PDF
Flick/David
GHTC sends FY19 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.

Learn More
GHTC announces changes to membership structure

GHTC announced today changes to its membership structure to better serve its existing membership and engage a broader group of global health R&D stakeholders in its advocacy activities. Effective now, GHTC will begin offering three types of membership.

Learn More
PATH/Gabe Bienczycki
STAT editorial cites GHTC joint letter

A joint letter co-drafted and endorsed by GHTC raising concerns about reported cuts to US Centers for Disease Control and Prevention Global Health Security Agenda (GHSA) activities was cited in a editorial in STAT.

View
PATH/Patrick McKern
New York Times cites GHTC joint letter on GHSA

In an article discussing the impact of cuts to US Centers for Disease Control and Prevention Global Health Security Agenda activities, the New York Timescited a letter to policymakers co-authored and endorsed by GHTC.

View
View All News
GHTC announces changes to membership structure

GHTC announced today changes to its membership structure to better serve its existing membership and engage a broader group of global health R&D stakeholders in its advocacy activities. Effective now, GHTC will begin offering three types of membership.

Learn More
Flickr/Helena Peixoto
GHTC statement on the President’s FY 2019 budget

The United States has long led the world in developing vaccines, drugs, diagnostics, and other technologies for neglected diseases and conditions that affect the world’s most vulnerable people, and the President’s budget proposal threatens to undermine this scientific and humanitarian legacy.

Learn More
PATH/Patrick McKern
GHTC welcomes House passage of the Global Health Innovation Act

GHTC welcomes yesterday’s passage by the US House of Representatives of the Global Health Innovation Act (H.R. 1660), a bipartisan bill that will strengthen efforts by the US Agency for International Development (USAID) to develop lifesaving drugs, vaccines, and other health technologies for people in need around the world.

Learn More
GHTC honors Senator Coons, Congressman Cole, and the dapivirine microbicide ring with Innovating for Impact Awards

Esteemed leaders from across the US government, industry, and the global health and medical research communities gathered at the Newseum in Washington, DC yesterday for GHTC’s Innovating for Impact Awards to celebrate US commitment to global health R&D and recognize Senator Chris Coons (D-DE) and Congressman Tom Cole (R-OK) for their congressional leadership on this issue. GHTC also honored the partnership that developed the dapivirine microbicide ring—a woman-centered HIV prevention tool—for its efforts to advance this groundbreaking new technology.

Learn More
PATH/Aaron Joel Santos
GHTC launches call for nominations for Innovating for Impact Awards

GHTC's new Innovating for Impact Awards initiative will celebrate the often under-recognized partnerships and political champions that drive global health R&D. The nomination deadline is September 20, 2017.

Learn More
View All Announcements
PATH/Gabe Bienczycki
Research Roundup: Polio surveillance gaps and new breakthroughs in Crimean-Congo hemorrhagic fever and preventing HIV transmission

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: Excess iron may lead to a harder malaria fight, brain damage and Zika in infants, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: R&D to defeat MRSA, West Nile Virus, and malaria-carrying mosquitoes

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Flickr/55thstreet
Global health and medical research saved from the chopping block in 2018 spending bill

What global health R&D advocates need to know about the 2018 omnibus spending bill.

Read More
PATH/Gabe Bienczycki
Research Roundup: Updates in vaccine research and development and understanding parasitic hookworms

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog
PATH/Gabe Bienczycki
STAT editorial cites GHTC joint letter

A joint letter co-drafted and endorsed by GHTC raising concerns about reported cuts to US Centers for Disease Control and Prevention Global Health Security Agenda (GHSA) activities was cited in a editorial in STAT.

View
PATH/Patrick McKern
New York Times cites GHTC joint letter on GHSA

In an article discussing the impact of cuts to US Centers for Disease Control and Prevention Global Health Security Agenda activities, the New York Timescited a letter to policymakers co-authored and endorsed by GHTC.

View
PATH/Matt Steele
GHTC advocacy on GHSA mentioned in Lancet

GHTC's advocacy on the Global Health Security Agenda was mentioned in a Lancet article exploring the impact of spending cuts and leadership changes at the US Centers for Disease Control and Prevention.

View
PATH/Patrick McKern
Washington Post Editorial Board cites GHTC joint letter in opinion

The Washington Post Editorial Board cited a joint-letter co-authored and endorsed by GHTC in an opinion piece calling for the Administration to provide funding to sustain the US Centers for Disease Control and Prevention activities to support he Global Health Security Agenda.

View
PATH/Gave Bienczcki
CNN article on cuts to CDC epidemic programs cites GHTC joint letter

In an article exploring the impact of cuts to US Centers for Disease Control and Prevention Global Health Security Agenda activities, CNN cited a letter to policymakers co-authored and endorsed by GHTC.

View
View All GHTC in the Media
University of Maryland Institute of Human Virology
GHTC welcomes Robert Redfield as CDC director

GHTC sent a letter welcoming Dr. Robert Redfield as the new Centers for Disease Control and Prevention (CDC) director and urging him to prioritize global health R&D at CDC.

PDF
Flick/David
GHTC sends FY19 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.

Learn More
PATH/Patrick McKern
GHTC welcomes Alex Azar as HHS Secretary

GHTC sent a letter welcoming Alex Azar as the new Secretary of Health and Human Services (HHS), urging him to prioritize global health R&D efforts at HHS.

PDF
PATH/Patrick McKern
GHTC sends letter expressing concern about reported cuts to CDC GHSA activities

GHTC jointly with other civil society organizations sent a letter raising concerns over recent reports that the US Centers for Disease Control and Prevention (CDC) plans to dramatically scale back its activities to support the Global Health Security Agenda (GHSA). The letter notes the vital role of this program in promoting global health security and protecting the health and national security of Americans.

PDF
GHTC issues statement on R&D for public health preparedness at WHO Executive Board meeting

GHTC issued a statement at the 142nd session of the World Health Organization (WHO) Executive Board welcoming efforts by WHO to advance the Research and Development Blueprint for Action to Prevent Epidemics, which is integral part of ensuring the global community has to right tools to prevent and combat epidemics. The statement was issued in partnership with the Global Health Council, PATH, the American Academy of Pediatrics, and the Infectious Disease Society of America.

PDF
View All Advocacy Actions

Events

GHTC Event

GHTC
Return on Innovation: How global health R&D is paying dividends in your state
GHTC
Learn More

GHTC Event

PATH/Gabe Bienczycki
Getting Local with Global Health Security: A Path Toward Sustainable Action
GHTC, GHC, PATH, GHSA Next Generation Network, MSH, GHSAC, NTI
Learn More

Member Event

PATH/Gabe Bienczycki
Accelerating Progress: Planning, Prioritization, and Partnerships to Advance Global Health Security
Global Health Security Agenda Private Sector Roundtable, PATH, Resolve to Save Lives, World Bank
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org